Effects of Modified Risk Tobacco Product Claims on Consumer Responses.

We found evidence that MRTP claims promoted health halo effects. In light of these findings, FDA should require research on halo effects prior to authorization. Further, if an MRTP claim is authorized, FDA should require tobacco manufacturers to conduct post-market surveillance of how the claim affects consumer understanding, including partial switching perceived risk and exposure beliefs, as well as monitoring of dual-use behaviors.